chevron_leftBack
As of 24 April 2025, Haleon plc has a market cap of $45.57B USD, ranking #428 globally and #21 in the United Kingdom. It ranks #41 in the Healthcare sector, and #4 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$45.57BUSD
34.34B GBP
Enterprise Value
$56.2BUSD
42.36B GBP
Revenue (TTM)
$14.9BUSD
11.23B GBP
EBITDA (TTM)
$3.56BUSD
2.68B GBP
Net Income (TTM)
$1.91BUSD
1.44B GBP
EBITDA Margin
24%
Profit Margin
13%
PE Ratio
24.2
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Brian McNamara
open_in_new
Employees
24,561
Founded
1715
Website
haleon.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.5% | -1% | -3.6% | 2% | 0.8% | 15% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
HLN
Haleon PLC
ISIN: GB00BMX86B70
Shares Out.:
Shares Outstanding:
9.026B1
Shares Float:
8.786B2
|
381 GBX | |
|
H6D0
Haleon PLC
ISIN: GB00BMX86B70
|
4.52 EUR | |
|
H6D0
Haleon PLC
ISIN: GB00BMX86B70
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
4.50 EUR | |
|
NYSE
MIC: XNYS
|
HLN
Haleon PLC ADR
ISIN: US4055521003
Shares Out.:
Shares Outstanding:
4.513B1
Shares Float:
4.513B2
|
10.23 USD |
|
HLN
(HLN/N)
Haleon PLC
ISIN: GB00BMX86B70
|
99.17 MXN | |
|
HLNCF
Haleon PLC
ISIN: GB00BMX86B70
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
5.33 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Haleon plc
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
